JPRN-UMIN000039146招募中未知
Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver - Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients who are suspected to have ileus. 2. patients with severe CKD. 3, patients with severe liver dysfunction (C-P: B or C). 4. Patients with uncontrolled malignancy.
研究者
相似试验
招募中
不适用
Effect of erobixibat on liver dysfunction in patients with chronic constipatioiver dysfuncitonJPRN-UMIN000039833Osaka Medical College20
招募中
不适用
Expression of factors involved in bile acid metabolism throughout the gastrointestinal tract Amendement: Expression of HIF-1alpha protein in upper GI tractusindirect Crohn's Diseaseno direct abberations are invistigated10018012NL-OMON33749Erasmus MC, Universitair Medisch Centrum Rotterdam50
尚未招募
不适用
The physiological role of bile acid‐mediated glucagon‐like peptide‐1 release in humans: The Cerebrotendinous Xanthomatosis Mixed Meal Test study.NL-OMON23193AMC28
已完成
1 期
Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult ParticipantsPruritusNCT05133830GlaxoSmithKline52
进行中（未招募）
1 期
A trial of a new drug, obeticholic acid, in patients with diarrhoea caused by bile acidsBile acid diarrhoea (also known as bile acid malabsorption)EUCTR2011-003777-28-GBImperial College London and Imperial College Healthcare NHS Trust35